The BTLA–HVEM axis restricts CAR T cell efficacy in cancerPuneeth Guruprasad, Marco Ruella, Yong Gu Lee et al.|Nature Immunology|2024Cited by 41
Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engagerZhuo Yang, Peng Wu, Jaroslav Žák et al.|Nature Biomedical Engineering|2024Cited by 35
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human studyYunlin Zhang, Marco Ruella, Mathew G. Angelos et al.|Molecular Cancer|2023Cited by 32
Pharmacological targeting of mitophagy via ALT001 improves herpes simplex virus 1 (HSV1)-mediated microglial inflammation and promotes amyloid β phagocytosis by restricting HSV1 infectionSoo Jin Oh, Ok Sarah Shin, Seok Tae Choi et al.|Theranostics|2025Cited by 6